Side-by-side comparison of AI visibility scores, market position, and capabilities
Shenzhen-listed (SZSE: 002352) SF Express China largest time-definite courier with 85+ cargo aircraft at ~$37B revenue; premium direct-operation model competing with ZTO and Cainiao for domestic and international cross-border logistics.
SF Express (SF Holdings, 顺丰控股) is a Shenzhen, China-based integrated logistics company — listed on the Shenzhen Stock Exchange (SZSE: 002352) — operating China's largest time-definite express delivery network with comprehensive coverage of 31 provinces, 300+ cities, and international service to 70+ countries, generating approximately RMB 270 billion ($37 billion USD) in annual revenue in 2024 and serving hundreds of millions of Chinese consumers and businesses through express delivery, e-commerce fulfillment, cold chain logistics, freight, supply chain management, and international cross-border shipping. Founded in 1993 by Wang Wei in Guangdong province, SF Express built its business on a proprietary direct-operation model (owning aircraft, trucks, and sorting facilities rather than franchising) that enabled the premium service reliability that established its brand in China's corporate express market.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.